Generation Bio Co.
General ticker "GBIO" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $42.7M (TTM average)
Generation Bio Co. follows the US Stock Market performance with the rate: 16.6%.
Estimated limits based on current volatility of 2.3%: low 5.10$, high 5.33$
Factors to consider:
- Total employees count: 115 (-33.9%) as of 2024
- Top business risk factors: Operating losses, Need for additional capital, Limited operating history, Labor/talent shortage/retention, Product development risks
- Current price 19.3% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [6.47$, 21.40$]
- 2025-12-31 to 2026-12-31 estimated range: [5.63$, 17.79$]
Financial Metrics affecting the GBIO estimates:
- Negative: with PPE of -5.5 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -122.58 <= 0.33
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: 18.93 < Shareholder equity ratio, % of 37.29 <= 41.86
- Positive: Investing cash flow per share per price, % of 130.84 > -0.66
Short-term GBIO quotes
Long-term GBIO plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $5.90MM | $19.89MM |
| Operating Expenses | $141.18MM | $144.47MM | $162.28MM |
| Operating Income | $-141.18MM | $-138.56MM | $-142.39MM |
| Non-Operating Income | $4.54MM | $11.95MM | $10.72MM |
| R&D Expense | $96.72MM | $93.62MM | $61.30MM |
| Income(Loss) | $-136.64MM | $-126.61MM | $-131.67MM |
| Profit(Loss)* | $-136.64MM | $-126.61MM | $-131.67MM |
| Stockholders Equity | $282.49MM | $203.13MM | $86.20MM |
| Assets | $376.26MM | $374.76MM | $231.20MM |
| Operating Cash Flow | $-102.45MM | $-52.74MM | $-88.56MM |
| Capital expenditure | $8.80MM | $7.40MM | $2.40MM |
| Investing Cash Flow | $-192.51MM | $-9.70MM | $94.53MM |
| Financing Cash Flow | $12.99MM | $35.82MM | $0.25MM |
| Earnings Per Share** | $-23.51 | $-19.63 | $-19.76 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.